Quoin Pharmaceuticals, Ltd.
10-K
March 26, 2026
Key Highlights
- Focused development of lead drug candidate QRX003 for rare skin diseases.
- Strategic 1-for-35 reverse stock split executed to maintain Nasdaq listing.
- Active pursuit of clinical milestones to potentially secure a pharmaceutical par...
Read Analysis
🤖 AI Generated